Company / SG&A Expense
Medline Inc. SG&A Expense History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$4.5B
FY2025
5-year range
$3.9B / $4.5B
FY2023-FY2025
Trend
+10.1%
vs FY2024
Sector context
#16 of 158
Health Care
What the data says
Among 158 Health Care companies, Medline Inc. is in the bottom 10% for sg&a expense. Increased from $3.9B to $4.5B over the past 2 years.
Based on SEC 10-K filings.
$4.5B in FY2025. Top quartile in the Health Care sector.
Increased from $3.9B to $4.5B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 158This company $4.5B Sector average $175.9B
▼
-97.4% below sector average
Key checks
Key Insights
- In FY2025, sg&a expense increased 10.1% year-over-year.
- Ranks #16 out of 158 companies in the Health Care sector.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.5B | +10.1% |
| FY2024 | $4.1B | +6.2% |
| FY2023 | $3.9B | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026